Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Thumbnail Image Read more about Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
Affimed Announces Completion of Enrollment in REDIRECT, the Registration-Directed Study of AFM13 in PTCL Thumbnail Image Read more about Affimed Announces Completion of Enrollment in REDIRECT, the Registration-Directed Study of AFM13 in PTCL
Jazz Pharmaceuticals to Present Data Showcasing Vyxeos Clinical Advances at ASH 2021 Annual Meeting Thumbnail Image Read more about Jazz Pharmaceuticals to Present Data Showcasing Vyxeos Clinical Advances at ASH 2021 Annual Meeting
Secura Bio Announces the Presentation of New COPIKTRA® (duvelisib) Data for the Treatment of Patients with Relapsed or Refractory PTCL Thumbnail Image Read more about Secura Bio Announces the Presentation of New COPIKTRA® (duvelisib) Data for the Treatment of Patients with Relapsed or Refractory PTCL
argenx to Present Clinical Update on Cusatuzumab at 63rd Annual ASH Meeting Thumbnail Image Read more about argenx to Present Clinical Update on Cusatuzumab at 63rd Annual ASH Meeting
OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development Thumbnail Image Read more about OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development
Yescarta® Is First CAR T-cell Therapy to Report Five-Year Survival Data From Pivotal Study Showing Durable Long-Term Survival in Patients With Refractory Large B-cell Lymphoma Thumbnail Image Read more about Yescarta® Is First CAR T-cell Therapy to Report Five-Year Survival Data From Pivotal Study Showing Durable Long-Term Survival in Patients With Refractory Large B-cell Lymphoma
New Research on Magrolimab Provides Key Insights as Gilead Rapidly Expands Research in AML Thumbnail Image Read more about New Research on Magrolimab Provides Key Insights as Gilead Rapidly Expands Research in AML
NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma Thumbnail Image Read more about NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhibitor KO-539 in Combination with Venetoclax Thumbnail Image Read more about Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhibitor KO-539 in Combination with Venetoclax
